Company Filing History:
Years Active: 2025
Title: Zhibo Luo: Innovator in Pharmaceutical Chemistry
Introduction
Zhibo Luo is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of RET inhibitors. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.
Latest Patents
Zhibo Luo's latest patents include innovative compounds that serve as RET inhibitors. The first patent, titled "Pyrazolopyridine compound as RET inhibitor and application thereof," discloses a series of pyrazolopyridine compounds. These compounds are specifically designed for the preparation of RET kinase inhibitors aimed at treating various conditions. The second patent, "Nitrogen-containing spiro derivative as RET inhibitor," presents a series of compounds featuring a nitrogen-containing spiro structure. This patent also focuses on the application of these compounds in the development of RET kinase inhibitors.
Career Highlights
Zhibo Luo is currently associated with Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., specifically at the Baiyunshan Pharmaceutical General Factory. His role in this esteemed organization allows him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Zhibo Luo has collaborated with notable colleagues, including Jiansong Wang and Shuhui Chen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Zhibo Luo's contributions to the field of pharmaceutical chemistry, particularly through his patents, highlight his role as an influential inventor. His work continues to impact the development of effective treatments, showcasing the importance of innovation in healthcare.